Ego dissolution, and why it isn't scary on paper

"Ego death" is the phrase the internet chose, and it is a terrible one: it makes a temporary shift in self-experience sound like an annihilation event. The research language is duller and much more useful.

What is being described

Ego dissolution refers to a reduction in the sense of being a bounded, separate self. The line between me and not-me gets less distinct. People commonly describe it as merging, dissolving, or being part of something continuous rather than looking at it from outside.

Researchers measure it, which is the part most popular coverage misses. Nour and colleagues validated the Ego Dissolution Inventory in 2016, an eight-item scale, using data on 1,828 drug experiences from 691 people. The Altered States of Consciousness scale contributes two relevant dimensions with wonderfully precise names: Oceanic Boundlessness for the expansive, connected version, and Dread of Ego Dissolution for the frightening version. There is also the Mystical Experience Questionnaire, validated in 2015 across five laboratory studies, which includes a scoring method for what researchers will formally call a "complete mystical experience."

Two things follow from the existence of these scales. This is a describable, gradable experience rather than an ineffable one. And researchers were careful enough to build separate measures for the beautiful version and the terrifying version, because both happen.

Why the field cares

Because the intensity of the experience appears to track how much better people get. Roseman, Nutt and Carhart-Harris reported in 2018 that in 20 patients with treatment-resistant depression, Oceanic Boundlessness and Dread of Ego Dissolution scores from the high-dose session both related to depression outcomes five weeks later. Both 2016 cancer trials, Griffiths at Johns Hopkins and Ross at NYU, reported that mystical-type experience partially mediated the reduction in anxiety and depression, and that this held separately from the overall intensity of the drug effect.

That word "partially" does a lot of work and is usually dropped. So is the caveat the Roseman authors put in their own discussion: causality cannot be established from a correlational design, samples are small, and unmeasured components of the therapy may be playing important roles.

There is a genuine structural problem here. In a trial, the intensity of the experience co-varies with preparation, rapport, music and expectation. Untangling "the experience healed them" from "the conditions that produced a strong experience also produced a good outcome" has not yet been done. It is an open question, argued in print by named scientists: David Yaden and Roland Griffiths on the side of the subjective effects mattering causally, David Olson on the side of the underlying biology being what counts.

What the brain is doing

Imaging links ego dissolution to reduced integrity of large-scale brain networks. Lebedev and colleagues in 2015 found the experience under psilocybin was associated with decreased connectivity between the medial temporal lobe and higher cortical regions, and disintegration of the salience network. Under LSD, Tagliazucchi and colleagues found increased global connectivity correlating with ego dissolution.

Those sound contradictory, and mechanistically the tension is unresolved. Worth noting because a great deal of popular writing attributes the ego-dissolution findings to the default mode network alone, which is not what these papers report.

The difficult version, honestly

Carbonaro and colleagues surveyed 1,993 people about their single worst mushroom experience, published in 2016. The findings are worth quoting properly rather than selectively. Thirty-nine percent rated it among the five most challenging experiences of their life. Eleven percent put themselves or others at risk of physical harm. Among those whose experience was more than a year earlier, 7.6% had sought treatment for enduring psychological symptoms. Three cases were associated with the onset of lasting psychotic symptoms and three with attempted suicide.

And: 84% said they benefited from the experience. Greater difficulty was associated with greater enduring gains in wellbeing, while longer duration of difficulty was associated with less.

That is a survey of people volunteering their worst experiences, so it is not an incidence rate for anything. But it captures something the mythology gets wrong in both directions. Difficult is not the same as damaging, and it is not a guarantee of insight either. What the paper's own conclusion emphasises is context: risky behaviour and lasting distress are extremely rare when psilocybin is given to screened, prepared and supported participants.

Why it lands as hopeful

The recurring report is not that the self was destroyed but that it turned out to be less solid, and less central, than assumed. People describe returning with the sense that the story they tell about themselves is a story. For anyone whose story has become punishing, that is not a frightening idea. It is the most practical thing in the literature.

Integrating My Universe carries this one: a small mushroom, cross-legged, with a whole galaxy overhead, taking it one breath at a time.